Apelin-13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI-3K/Akt and MAPK/Erk Signaling Pathways.

Diabetic macular edema is major cause of vision loss associated with diabetic retinopathy. Breakdown of blood-retinal barrier, especially inner BRB, is an early event in pathogenesis of DR. Apelin, an endogenous ligand of APJ, mediates angiogenesis and is involved in the development of DR. The prese...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International Vol. 2018; pp. 1 - 18
Autores principales: Li, Yang, Bai, Yu-jing, Jiang, Yan-rong, Yu, Wen-zhen, Shi, Xuan, Chen, Li, Feng, Jing, Sun, Gui-bo
Formato: pictorial research tables/charts Journal Article
Publicado: Wiley-Blackwell 4/4/2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128871516&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 128871516
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 4/4/2018
      vid: 2018
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        128871516
        128871516
        128871516
        10.1155/2018/3242574
        128871516
      ppf: 1
      ppct: 17
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Apelin-13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI-3K/Akt and MAPK/Erk Signaling Pathways.
      aug:
        au:
          Li, Yang
          Bai, Yu-jing
          Jiang, Yan-rong
          Yu, Wen-zhen
          Shi, Xuan
          Chen, Li
          Feng, Jing
          Sun, Gui-bo
        affil: Department of Ophthalmology, Peking University People’s Hospital, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Beijing Key Laboratory for the Diagnosis and Treatment of Retinal and Choroid Diseases, Beijing 100044, China
      sug:
        subj:
          Diabetes Mellitus Complications
          Macular Degeneration Prevention and Control
          Capillary Permeability Drug Effects
          Growth Substances Pharmacodynamics
          Human
          Vitreous Body Analysis
          In Vitro Studies
          Models, Biological
          Glucose Administration and Dosage
          Cytoskeletal Proteins Metabolism
          Membrane Proteins Metabolism
          Cell Proliferation
          Cell Migration Assays
          Phosphorylation
          Protein Kinases Metabolism
          Signal Transduction
          In Vivo Studies
          Animal Studies
          Mice
      ab: Diabetic macular edema is major cause of vision loss associated with diabetic retinopathy. Breakdown of blood-retinal barrier, especially inner BRB, is an early event in pathogenesis of DR. Apelin, an endogenous ligand of APJ, mediates angiogenesis and is involved in the development of DR. The present study aimed to investigate effects and mechanism of apelin-13 in vascular permeability during DME. We verified apelin-13 was upregulated in DME patients’ vitreous. High glucose incubation led to a progressive increase of apelin-13, APJ, cytoskeleton, and tight junction proteins, including VE-Cadherin, FAK, Src, ZO-1, and occludin. Apelin-13 promoted HRMEC proliferation and migration and phosphorylation of both cytoskeleton and tight junction under both normal and high glucose conditions. Besides, apelin-13 activated PI-3K/Akt and MAPK/Erk signaling pathways, including PLC<italic>γ</italic>1, p38, Akt, and Erk both in HRMEC and in C57BL/6 mice. Meanwhile, F13A performed opposite effects compared with apelin-13. In<italic> in vivo</italic> study, apelin-13 was also upregulated in retina of<italic> db/db</italic> mice. Taken together, apelin-13 increased biologic activity of HRMEC, as well as expression of both cytoskeleton and tight junction in DME via PI-3K/Akt and MAPK/Erk signaling pathways. Apelin-13 as an early promoter of vascular permeability may offer a new perspective strategy in early treatment of DR.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N